Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study
https://pubmed.ncbi.nlm.nih.gov/31160171/
News & Events
An experiment in end-of-life care: Tapping AI’s cold calculus to nudge the most human of conversations
https://www.statnews.com/2020/07/01/end-of-life-artificial-intelligence/
Cancer Care Associates of York Joins the Quality Cancer Care Alliance’s National Network
https://www.newswire.com/news/cancer-care-associates-of-york-joins-the-quality-cancer-care-alliances-21160679
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105.
https://www.ncbi.nlm.nih.gov/pubmed/30487236 Drilon A, Fu S, Patel MR, Fakih M, Wang D, Olszanski AJ, Morgensztern D, Liu SV, Cho BC, Bazhenova L, Rodriguez CP, Doebele RC,… A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105.
Aligning With Cancer Centers To Spur Biosimilar Uptake
https://www.biosimilardevelopment.com/doc/aligning-with-cancer-centers-to-spur-biosimilar-uptake-0001
Reducing Cancer Costs Through Symptom Management and Triage Pathways.
Barkley R1, Soobader MJ2, Wang J2, Blau S3, Page RD4.https://www.ncbi.nlm.nih.gov/pubmed/30576262
What Is Data Science: Addressing the Uncertainty Behind Addressing Uncertainty
https://www.journalofclinicalpathways.com/commentary/what-data-science-addressing-uncertainty-behind-addressing-uncertainty
Artificial intelligence (AI) to improve patient outcomes in community oncology practices.
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e18098
Empower Physicians to Fight Financial Toxicity With Biosimilars
Author: Kathy Oubre, MS https://www.ajmc.com/journals/evidence-based-oncology/2019/december-2019/empower-physicians-to-fight-financial-toxicity-with-biosimilars